牛唐2019-03-16 14:58
$Akari Therapeutics(AKTX)$ FDA同意coversin在HSCT-TMA适应症的关键阶段的实验设计,引发了翻倍的增长,如果后续数据好的话,未来市值有望跟相$Ra Pharmaceuticals(RARX)$ 、$奥麦罗制药(OMER)$ 相比查看全文
啃医药股的熊猫2019-03-15 11:30
【汇众医疗】3月14日上涨医药股盘点:生物制药 Akari Therapeutics 拔头筹,涨幅224.18%$$Akari Therapeutics(AKTX)$ $$Guardant Health(GH)$ 3月12日涨幅最大的三支医药股分别是:制药公司Akari Therapeutics上涨224.18%,肿瘤学公司Guardant Health上涨27.64%,康纳斯制药公司Conatus Pharmaceut...查看全文
$Akari Therapeutics(AKTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-080539 Size: 21 KB 网页链接
$Akari Therapeutics(AKTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-080540 Size: 21 KB 网页链接
$Akari Therapeutics(AKTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-080541 Size: 21 KB 网页链接
$Akari Therapeutics(AKTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-080542 Size: 21 KB 网页链接
$Akari Therapeutics(AKTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-080538 Size: 21 KB 网页链接
$Akari Therapeutics(AKTX)$ 8-K Current report, item 5.07 Accession Number: 0000950170-24-079669 Act: 34 Size: 307 KB 网页链接
$Akari Therapeutics(AKTX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-073133 Act: 34 Size: 58 KB 网页链接
$Akari Therapeutics(AKTX)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001213900-24-050884 Act: 34 Size: 49 KB 网页链接
$Akari Therapeutics(AKTX)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0000950170-24-069414 Act: 34 Size: 332 KB 网页链接
$Akari Therapeutics(AKTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-068770 Size: 24 KB 网页链接